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Introduction
Multicellular organisms necessitate a communi-
cation system to grow and function; in complex mul-
ticellular organisms, like humans, cell-to-cell commu-
nication becomes the basis of life.
Intercellular communication in higher animals
not only allows structural and functional coordination
amongst cells, but also regulates cellular development,
differentiation, organisation and division. The impor-
tance and complexity of cell-to-cell communication
has attracted the attention of various areas of science
over the last 50 years.
Although inter-cell communication occurs
throughout adulthood, it has been greatly investigated
during embryological development.
In the last 30 years, developmental biologists
have proved and detailed the existence of signalling
molecules which regulate the main steps of embryoge-
nesis.
The Wnt family of signalling proteins has been
found to be involved in embryonic patterning, in the
homeostasis of adult tissue self-renewal and in the
process of carcinogenesis. Such a diverse spectrum of
action is due to the Wnt signal being pleiotropic; there-
fore, a vast array of cellular responses is coordinated by
the Wnt proteins and their downstream effectors.
The Wnt proteins are secreted lipid-modified
proteins (1) that, by binding to specific cell surface re-
ceptors, initiate diverse intracellular signalling path-
ways, which culminate in the activation of target genes
and different cellular responses.
The deregulation of signalling pathways related
to fundamental cellular functions, including Wnt,
leads to alterations in several features of the cell, in-
ducing tumourigenesis.
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Abstract. The Wnt pathway is a signal-transduction cascade that mediates communication between cells;
the Wnt pathway is involved in key steps during embryological development and in the maintenance of adult
tissue homeostasis. Mutational dysregulation of Wnt cascade components has been observed in diverse hu-
man pathological conditions and in oncogenic transformations. For these reasons, the Wnt signalling path-
way has acquired growing interest in scientific and medical research over recent years. This review outlines
the biochemical and functional features of the Wnt cascade with particular emphasis on a detailed function-
al analysis of all key players. In this instance, the regulations of the pathway have also been covered, empha-
sizing novelty in this regard. Furthermore, past and present studies on Wnt have been included, as well as a
prediction of scientific progress, which may be made in this rapidly evolving field, in the near future; the re-
view also embraces considerations on how further understanding of the Wnt pathway will provide important
insight into managing human diseases. (www.actabiomedica.it)
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3. The WNT pathway
3.1 The Wnt pathway story: A tale 700 million years long
The last few decades have witnessed the discov-
ery of numerous signalling families, since the bone
morphogenetic proteins (BMPs) in 1977 (2). In the
late 80s, the Wnt pathway was revealed. Prior to this,
the wingless gene had already been identified in
Drosophila, before its murine homolog, int-1, was de-
tailed (3).
The Wingless gene (wg1) was discovered in
Drosophila melanogaster with mutant phenotypes on
wings and halteres 30 years ago (4).
Years later, new insights came from the analysis
of the mouse mammary-tumour virus (MMTV),
which integrates in a common site of the genome (5);
the region was identified as the promoter of a gene
called Int-1 for integration (6). Sequence analysis
demonstrated the murine proto-oncogene Int-1 as an
orthologue of the Drosophila segment polarity gene
Wingless (7); the fusion of the two names gave rise to
the term “Wnt”, also used as acronym for “wingless-
type” (7).
Since the discovery of Int-1 (now Wnt1), many
other Wnt genes have been identified in vertebrates
and invertebrates, from hydra to humans. Neverthe-
less, they are absent from plants (8).
However, more downstream members of the Wnt
signalling cascade, such as β-catenin, have been dis-
covered in primitive organisms such as Dictyostelium
(9) and plants (10). This suggests that an ancient Wnt-
independent mechanism existed for the intracellular
activation of Wnt transcriptional effectors like β-
catenin, before the evolution of animals even started.
The evolutionary origin of the Wnt family has
been traced back to primitive diploblasts (11); in
members of the Cnidaria family, bona fide Wnt mol-
ecules have been found, emphasizing the amazing
conservation of the Wnt signalling molecules
throughout evolution (12, 13).
The evolutionary analysis of Wnt genes has been
aided by the availability of genetic information from
the sequencing of various organisms’ genomes. Cur-
Figure 1. Evolutionary origins of selected components of the Wnt pathway and their location within the cell
A schematic representation of a cell, in which major components of the Wnt signalling cascade have been placed in their respec-
tive locations (in italics). The evolutionary origins of these molecules are shown on the right hand side.
It is interesting to notice that the most distal components of the Wnt pathway (ie. the intracellular molecule β-catenin) are highly
conserved in very primitive organisms and plants
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rently, 19 WNT genes have been found in human
(Table 1) and other mammals; they reveal unique ex-
pression patterns and distinct functions, although
some redundancies are observed (Table 1) (14). Be-
tween vertebrate species there is extensive conserva-
tion of Wnt gene sequence and structure (15). Also,
between Drosophila and vertebrate Wnt molecules, an
extensive conservation of biological and biochemical
functions has been noticed, which permits the identi-
fication of orthologues. Furthermore, the conservation
of clusters of genes between vertebrates and inverte-
brates (Drosophila) indicates the presence of a Wnt
ancestral cluster (16) common to all bilateral animals
(17), dating back 700 million years.
Table 1. Human Wnt Genes Details. Modified from Table 2 (46)
Gene name Cancers (& Human Diseases) Fetal expression Adult expression
WNT1 Gastric, Pancreatic, Breast  Cancer / Spleen, Bone, Uterus, Colon
WNT2 Breast Cancer Placenta Lung, Breast
WNT2B/13 Breast, Cervical, Gastric Cancer Brain, Lung & Kidney Heart, Brain, Lung, Prostate, Testis,
Ovary, Intestine & Colon
WNT3 Leukemia; Breast Cancer; / Breast
Tetra-Amelia
WNT3A Breast Cancer / /
WNT4 Breast, Endometrial Cancer; Kidney, Liver Breast, Endometrium, Adrenal Gland,
Mullerian-Duct Virilization Skeletal Muscle & Thyroid
WNT5A Lung, Breast, Prostate Cancer Heart, Lung /
WNT5B Leukemia; Gastric Cancer; Teratoma; Brain Prostate
Diabetes type 2
WNT6 Colorectal, Cervical Cancer Placenta Spleen
WNT7A Endometrial Cancer Placenta, Lung, Brain Kidney, Testis, Uterus, Brain
Limbs Development
WNT7B Teratocarcinoma; Breast, Lung, Brain, Lung, Kidney Brain, Lung, Prostate, Breast
Gastric Cancer
WNT8A Teratocarcinoma Embryonic Stem Cells /
(ESC) (?)
WNT8B Gastric, Breast Cancer Brain (Forebrain) /
ESC (?)
WNT9A Leukemia; / Skeletal Muscle, Heart
Previously WNT14 Breast, Gastric Cancer
WNT9B Connective tissue diseases Neurons Connective Tissues
Previously WNT15 
WNT10A Colorectal Cancer, Leukemia Kidney, Placenta Spleen
WNT10B Breast, Gastric Cancer / Heart, Skeletal Muscle
WNT11 Prostate Cancer Skeleton, Kidney, Lungs Heart, Liver, Skeletal Muscle, Pancreas
WNT16 (A & B) Leukemia / Spleen, Appendix, Lymph Nodes,
Pancreas
(?) = Not yet confirmed   
/ = Data not available in human           
Human diseases are shown in italic
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From the phylogenetic analysis, the Wnt molec-
ular pathway has emerged as “a quintessential aspect of
organized multicellular life” (18).
Also, the implication of Wnt in carcinogenesis
during the discovery of the first Wnt gene marked the
early onset of extensive Wnt research. Data have been
accumulated over the last decades, which allow this
literature review to be able to cover details of the Wnt
pathway, as well as clinical considerations about the
strong relationship between the Wnt signalling cas-
cade and human pathologies. At present, several ques-
tions are being addressed, whose answers will allow
the design of effective therapeutic strategies to be ap-
plied in curing diseases like cancer, in the near future.
3.2 Molecular mechanisms of the Wnt signal transduction
pathway
Wnts are lipid-modified, cystein-rich glycopro-
teins secreted by signalling cells. The Wnt proteins are
notoriously insoluble; the porcupine gene, in the Wnt
producing cells of Drosophila (19), is responsible for
the increase of Wnts hydrophobicity, through palmi-
toylation on a conserved cystein residue (Figure 2) (1).
This feature of Wnt molecules is critical for signalling,
but has hindered structural and biochemical charac-
terization of the proteins. It is known that human
Wnt proteins have very similar molecular weights,
from 39 kDa (Wnt7a) to 46kDa (Wnt10a).
The diffuse expression of Wingless in Drosophi-
la imaginal discs indicates that Wnt ligands function
as concentration-dependent long-range morpho-
genetic cues (20, 21). In order to relay the Wnt pat-
terning signal on distant cells, the proteins may be
transported via a vesicle-based mechanism, outside
the cell (22). Indeed, other transporting systems have
been proposed (23), yet it is still not clear how Wnts
are shuttled between cells and which molecules are
involved.
Once released into the extracellular milieu, the
Wnt ligands interact with multiple secreted proteins,
which modulate Wnt activity. This is a pivotal control
step to ensure the specificity of the activity of the Wnt
signal.
Wnt proteins can interact with the secreted He-
parin-sulfated proteoglycans (HSPGs), such as Dally
(division abnormally delayed) in Drosophila (24-26) and
the murine syndecan-1 (27). Although HSPGs have
been postulated to act as co-receptors present on tar-
get cells (26), experiments suggest the presence of ad-
ditional roles in the stabilization of Wnt proteins and
in aiding their transport between cells (28).
Molecules like SFRP (secreted frizzled-related
proteins) (29, 30) and WIF (Wnt inhibitory factor)
(31) are thought to be extracellular inhibitors of Wnt
signalling, because, by binding to the secreted Wnt
ligands, they sequester them and prevent them from
binding to the receptor of responding cells (32-35).
Nevertheless, SFRPs and WIFs may play a less unilat-
eral role than assumed, by changing and adapting
their functions depending on the Wnt expression lev-
el and the cellular context; moreover, they could act to
prevent degradation of the Wnt ligands and facilitate
their secretion and movement (36).
Two other related extracellular antagonists of the
Wnt molecules are Cerberus (37) and Coco (38); in
Xenopus, these two inhibitors can complex and act to
sequester Wnt ligands from their receptors.
The Wnt signalling pathway is initiated by the
Wnt molecules upon binding to seven-transmem-
Figure 2. Schematic diagram illustrating the structural elements of Wnt
Wnt molecules all contain a signal sequence at the amino terminus (S), followed by 23 (or 24) cysteines, whose distribution is high-
ly conserved; this latter characteristic may indicate that several intramolecular disulfide bonds aid Wnt proteins’ folding (15). The
arrow indicates the most N-terminal cysteine for the palmitate modification, identified via mass spectrometry by (45) and mapped
to C77 in the murine Wnt3a and C51 in Drosophila’s Wnt8. This cysteine is conserved in all Wnt proteins (1)
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brane receptors called Frizzled (Fz; (39, 40)). Fzs are a
family of serpentine receptors with seven-transmem-
brane-spanning domains and with a long amino-ter-
minus called CRD (cystein rich domain) to which
Wnt ligands directly bind (39, 41).
At this point, divergence between the different
Wnt signalling cascades occurs. If the Wnt ligands, as
well as binding to a member of the Fz family of re-
ceptors, simultaneously interact with co-receptors
LRP-5 or LRP-6, which are part of the low-density
lipoprotein receptor related protein family (LRP;
(42)), they will activate the intracellular Wnt canoni-
cal signalling pathway. On the other hand, if LRP is
not expressed on the responding cell’s surface, or it has
been down-regulated by inhibitory secreted factors,
Wnt molecules will only bind to the Fz receptor, trig-
gering the so-called non-canonical pathways; the pla-
nar cell polarity and the Wnt/Ca2+ non-canonical cas-
cades will not be discussed in this review (for further
reading, refer to recent reviews by (43, 44)).
3.2.1 The canonical Wnt signalling pathway
The best characterized and understood Wnt sig-
nalling cascade is the so-called β-catenin/Wnt canon-
ical pathway. The key transcriptional effector of this
pathway is β-catenin (45), whose accumulation with-
in the cytoplasm mediates diverse cellular responses.
The canonical pathway follows a linear genetic
cascade, but it involves numerous players (Table 2)
and interactions, which, for the sake of simplicity, will
not be quoted in detail.
Since Wnt molecules mediate paracrine, non-cell
autonomous signals, several control steps are indis-
pensably scattered throughout the Wnt cascade, to
ensure a spatially restricted pattern of Wnt mor-
phogens.
As described above, the initiation of the canoni-
cal pathway is marked by the binding of Wnt proteins
to both Frizzled transmembrane receptors and to
LRP-5 or LRP-6 (42). Upon binding, the Wnt signal
is transduced into the cell. The engagement of the
Wnt ligands to the Fz receptors induces differential
phosphorylation of the cytoplasmic mediator, Dishev-
elled (Dsh; (47)), an event regulated by numerous pro-
tein kinases, including Par1 (48). Notably, suggestions
have been forwarded that the interaction between Dsh
and Fz may be mediated by a heterotrimeric G pro-
tein, such as Gαο (49). Nevertheless, existing evi-
dences do not fully support the mechanistic basis for
these protein interactions.
The distinguishing characteristic of canonical
Wnt pathway activation is the augmentation of cyto-
plasmic levels of β-catenin. The available evidence in-
dicates that the phosphorylated Dsh undergoes con-
formational changes which mediate the dissociation of
Table 2 - Gene nomenclature of selected Wnt pathway members. The numerous components of the Wnt cascade may present dif-
ferent names for diverse organisms, still referring to the same molecule. Modified from Table 1 (46) 
Protein Human Mouse D. melanogaster C. elegans
β-catenin CTNNB1 Catnb Armadillo Bar-1
β -catenin; plakoglobin JUP Jup Armadillo (?) Wrm-1; hmp-2
APC APC; APCL Apc dApc; E-Apc Apr-1  
Axin AXIN (1 & 2) Axin dAxin Pry-1  
Dickkopf DKK Dkk Dickkopf ?  
Dishevelled DVL Dvl Disheveled Mig-5; dsh (1 & 2)  
Frizzled FZD Fzd Frizzled; Dfz Mom-5; lin-17; mig-1; cfz-4  
Groucho TLE Grg Groucho Unc-37  
GSK3β GSK3B Gsk3b Shaggy; Zeste white Sgg-1  
Legless BCL9 Lgl Legless ?  
LRP LRP (5 & 6) Lrp Arrow Lrp-1  
Pygopus PYGO Pygo Pygopus; Pygo ?  
TCF/LEF TCF; LEF Tcf/Lef dTcf/pangolin Pop-1
Wnt Wnt Int; Wnt Wingless (Wg) Mom (1 & 2); Lin-44; Egl-20
Cwn (1 & 2)
? = Not yet identified
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glycogen synthase kinase 3β (GSK3β), preventing β-
catenin degradation (50, 51); Frat-1 may also be in-
volved in the process (52). Thereby, the elevation of
cytoplasmic β-catenin levels initiates its translocation
into the cell nucleus.
Precisely how β-catenin is translocated into the
cell nucleus is not clear, since it does not contain a
clear nuclear localization sequence. Several studies
have been carried out in order to identify the proteins
responsible for β-catenin nuclear import. APC (ade-
nomatous polyposis coli) has been suggested as a pos-
sible candidate (53-56); alternatively, or in addition, a
recent report has proposed a plausible model in which
pygopus, along with the protein Bcl9/legless, com-
plexes with β-catenin and imports it into the cell nu-
cleus (57).
In the nucleus, β-catenin interacts with the
TCF/LEF family of transcription factors (58); per-
haps surprisingly, these DNA-binding proteins, rather
than β-catenin itself, bind to the DNA through a high
mobility group (HMG) box and promote activation of
target genes (59).
The final outcome of the Wnt/β-catenin canon-
ical pathway is the activation of specific genes. The
panoply of genes which are targeted by β-catenin is
constantly growing. The importance of these genes
becomes crucial because of the deep connection be-
tween the Wnt cascade activation and neoplastic
transformation (Table 3).
Significantly, many Wnt genes encode transcrip-
tion factors that are able to regulate Wnt activity by
feedback loops. An example of this fine-tuning of the
Wnt pathway at the cell surface is the regulation, by
Wnt genes, of the levels of the Frizzleds receptors,
LRPs and HSPGs (20, 42, 60).
In addition, the cytoplasmic negative regulators
of the Wnt cascade, naked cuticle (naked) and Axin2,
are direct targets of Wnt signalling.
It is surprising how the rigid Wnt pathway regu-
lation steps clash with the wide range of transcrip-
tional targets and outputs in multiple cells and tissue
types. In fact it is thought to be the cell, rather than
the Wnt signal itself, which determines the nature of
the response depending on environmental or intrinsic
aspects; therefore, the up or down-regulation of Wnt
genes and subsequent transcriptional effects are cell-
type specific.
The intricacies of the Wnt pathway regulation
do not simply relate to individual steps of the cascade
itself, but also reconnect to the multiple interactions
of the Wnt cascade with other cell signalling path-
ways. The interaction between Wnt and other sig-
nalling pathways, for example the Hedgehog cascade,
does not only have an antagonizing role, but may 
also promote a cellular collaboration which gives rise 
to different genetic outcomes. For further details,
the reader is referred to several reviews on the topic
(61-67).
Another important aspect that needs to be men-
tioned is the convergence of the Wnt/β-catenin cas-
cade and Cadherin pathway (68). Notably, cytoplas-
mic β-catenin is not only associated with Wnt sig-
nalling, but it is also connected to type I cadherin ad-
hesion molecules, mediating structural organization
and interactions between cells. The signalling regula-
tion of gap junction through β-catenin as an adher-
Figure 3. Schematic outline of the major components and
modulators of the Wnt pathway 
The central box in the diagram above indicates the main com-
ponents of the Wnt pathway and their interactions. The boxes
on the right hand side contain selected Wnt inhibitors, where-
as the boxes on the left hand side show major molecules pro-
moting the Wnt cascade.
NB. The lines locate the proteins within a specific step or to a
specific molecule of the Wnt pathway on which they act    
05-giunta  25-02-2010  15:21  Pagina 192
193A gust of WNT
ance-junction protein has been shown to have pro-
found implications in angiogenic processes in devel-
opment and disease (69). Furthermore, the link be-
tween cadherins and β-catenin may not only be relat-
ed to adhesion, but can also be used as a control tool
for the Wnt cascade; cadherin can act to sequester β-
catenin, preventing it from functioning in the Wnt
signalling pathway, and vice versa, cadherin may re-
lease it from the cell membrane and thus make β-
catenin available for Wnt signalling (70).
In the next section the role of Wnt signalling in
development, stem cell maintenance and cancer will
be elucidated. It is crucial to remember that to per-
form these functions the Wnt pathway may intersect
and synergize with the cadherin cascade and other
signalling pathways involved in cell adhesion and mi-
gration.
3.3 Development, adulthood and diseases: The variety 
of functions (and malfunctions) of the Wnt signalling
pathway 
At the onset of Wnt research, model organisms
such as Drosophila and Xenopus were powerful experi-
mental tools for the investigation of Wnt pathway
components and functions. The need to relating the
information coming from these organisms to humans
called for the adoption of mice models to bridge the
evolutionary gap for signalling pathway analysis. Ze-
brafish has recently acquired a major role as vertebrate
model for the study of Wnt-related human patholo-
gies and cancer.
In the Wnt field, a plethora of discoveries have
been made using these models; developmental func-
tions and pathological transformations driven by Wnt
molecules and downstream effectors have been dis-
covered via genetic experiments in lower organisms.
Mutant phenotypes, outcome of experimental meth-
ods including gene knock-out, gene gain-of function,
mutant and transgenic lines, chemical mutagenesis,
RNA interference and morpholino antisense oligonu-
cleotides injections, targeting Wnt pathway compo-
nents have been detailed, interpreted and related to
the functional role of individual Wnt molecules. Their
functions have been a paradigm to obtain a global pic-
ture of the Wnt signalling pathway.
3.3.1  Wnt signalling pathway harnesses the secret of life
In the light of the developmental studies under-
taken on the Wnt pathway, the functions of the Wnt
cascade in adulthood have been investigated.
One characteristic of the Wnt pathway that en-
compass both embryogenesis and adulthood is the
ability of the Wnt signal to augment a progenitor cell
population by simultaneously endorsing cell division
and inhibiting apoptosis and cellular commitment.
This observation has been made in central nervous
system development and function, as well as in gut
and lung development and intestinal and bronchial
epithelia maintenance (71).
These findings, together with the data from stud-
ies in human haematopoiesis (72), prompt for the es-
tablishment of a role for the Wnt pathway in stem cell
biology.
Much information about stem cells comes from
studies of the haematopoietic stem cells (HSC) (73),
that sustain the production of blood cells and cells of
the immune system during the lifetime of an individ-
ual. Although Wnt signalling is important in the
maintenance of multiple stem cells types (gut, epithe-
lial, etc.), as well as pluripotent human and mouse em-
bryonic stem cells, HSC will be used as example to de-
fine the role of the Wnt cascade in the preservation of
adult tissue homeostasis via control of stem cell prolif-
eration and differentiation.
HSC use Wnt ligands in an autocrine and
paracrine manner, by producing Wnt molecules them-
selves and by responding to the Wnt signals present in
the HSC native microenvironment (the so-called
stem cell niche). In vitro experiments in mice suggest
that Wnt proteins promote the growth of
haematopoietic progenitors and maintain them in an
undifferentiated state. In addition, they are able to
promote murine progenitor cells and HSC self-re-
newal, enabling repopulation of the haematopoietic
system after lethal irradiation (72, 74). Furthermore,
T-cell development and B-cell survival are mediated
by the Wnt signalling cascade (75, 76).
Intriguingly, it is not yet clear whether the role of
Wnt in stem cell expansion is mediated by the canon-
ical or non-canonical Wnt cascades, since β-catenin
has been demonstrated to be dispensable for
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haematopoiesis and lymphopoiesis (77). Although β-
catenin has been found to be not-essential for various
Wnt pathway roles in development and adulthood, it
does not necessarily mean that the canonical Wnt cas-
cade is not implicated in those functional activities;
rather, there could be compensatory mechanisms and
redundancies at the molecular level.
Other stem cell niche-derived signalling path-
ways exist, such as the Hedgehog (Hh), BMP and
Notch cascades; it would be interesting to investigate
the extent of the cross-talk and convergence between
the pathways and their distinct roles in stem cells ex-
pansion.
3.3.3 Wnt signalling and diseases: “With great power can
come dire consequences”
Loss of control of a signalling cascade with such
diverse functions as Wnt certainly has disastrous con-
sequences on human health. While Wnt signals si-
multaneously promote growth and prevent differenti-
ation of stem cells, one small insult can disrupt the
balance from a pool of undifferentiated stem cells to
one of aberrant cancer cell.
Following on from the previous chapter, consid-
ering the influence of Wnt pathway components on
HSC, Wnt dysregulation has been directly associated
with the development of leukemias. The same parallel
can be drawn in several other cases: colorectal cancer
and proliferating progenitors in the colonic epitheli-
um, adenomas and intestinal crypt progenitor stem
cells and, in regard to certain developmental abnor-
malities, a connection could be made going all the way
back to embryonic stem cells.
The molecular events responsible for oncogenic
transformation by altered Wnt signalling occur upon
its aberrant activation.
Constitutive activation of the Wnt cascade confers
to the cell two essential requirements for carcinogene-
sis: selective growth advantage for the onset of clonal
expansion and genetic instability to allow further muta-
tions to be accumulated by the cancer cells, facilitating
its advancement and spreading. β-catenin can therefore
be seen as a proto-oncogene; its ectopic activation may
be caused by direct mutation of the β-catenin gene
CTNNB1, often preventing β-catenin degradation, or
by mutation to the Wnt pathway’s intracellular antago-
nists APC and Axin; both events lead to the ectopic ac-
cumulation of β-catenin within the cell and the over-
expression of several Wnt target genes responsible for
cell malignancy and modulators of metastatis.
Hence, the real mediators of oncogenesis are the
target genes of the Wnt cascades; examples of genes
transcribed when the Wnt cascade is activated include
the proto-oncogenes c-myc, which stimulate G1/S
phase progression, cyclinD1 that also promotes pro-
gression through the cell cycle, survivin, an anti-apop-
totic gene that leads to the accumulation of trans-
formed cells, and c-Met, the receptor for an epithelial
growth factor that promotes cell migration and inva-
sion. Thus, direct connections can be drawn between
the function of Wnt target genes and specific features
of cancer cells. Moreover, each Wnt target gene affects
numerous cellular processes and may contribute to
further neoplastic changes.
Similarly, a crucial role in tumourigenesis is
played by the genes silenced by the activation of the
Wnt pathway; the inhibition of such genes has been
associated with loss of terminal differentiation and in-
sensitivity to growth inhibitors, both key features of
many tumours.
Loss-of-function of APC is a significant cause of
colorectal cancer (CRC), accounting for 85% of all
sporadic CRC. It is also responsible for a rare human
inherited autosomal dominant condition, called famil-
ial adenomatous polyposis (FAP; (78)). FAP consists
of multiple colorectal adenomas and increased risk of
malignancies affecting the brain and the thyroid. This
is a well-studied example of degenerative disease
caused by misregulation of the Wnt pathway.
Loss-of-function mutation in the LRP5 receptor
gene, due to a single amino-acid substitution, makes it
refractory to Dkk-mediated Wnt canonical cascade
inhibition, leading to bone abnormalities and to fa-
milial exudative vitreopathy (FEVR), a retinal heredi-
tary disorder (79, 80). Alzheimer’s disease and cardio-
vascular pathologies have also been attributed to a
malfunctioning Wnt pathway (Table 3) (81, 82).
The widespread occurrence of the Wnt pathway
in human physiological and pathological processes
makes this pathway one of the most pivotal cellular
signalling cascades; it can be said that proper function
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and tight control of the Wnt pathway are essential re-
quirements for physiological “immortality”.
3.4 The forthcoming “WNT Storm”:Therapeutical appli-
cations and future perspectives
The collaboration between medicine and science
has initiated a new era for cancer treatments and ther-
apies. Chemotherapy, an indispensable step in the
treatment of almost all cancers in advanced stage, is
going through a paradigm change. The cancer drugs
and combinational therapies currently used, which act
on fast dividing cells by non-selective inhibition of
DNA replication, have enhanced patient survival over
the past decades. Yet these cytotoxic agents, adminis-
trated daily to thousand of patients all over the world,
result in substantial toxicity causing heavy side effect.
New agents against cancer- and cell-specific targets
represent the future weapons in the battle against can-
cer. In this perspective, the investigation of the Wnt
pathway becomes an invaluable tool for the search of
new anticancer therapeutic targets and for the emerg-
ing translational therapy.
Imatinib Mesylate (IM, Gleevec) is probably the
best example of a rationally-designed “molecular” drug,
manufactured on the basis of research data available on
cancer. IM inhibits the oncogenic fusion protein prod-
uct of the leukemogenic BCR-ABL translocation in-
volved in chronic myelogenous leukemia (CML). This
molecular event causes the uncontrolled growth of
white blood cells. Recently, it has been observed that
IM also leads to down-regulation of β-catenin in hu-
man colorectal cancer cells. Although this is not the
primary effect of IM, it indicates that targeting tyro-
sine kinases alters the phosphorylation steps required
for correct Wnt pathway signalling (84).
Endostatin is a protein able to inhibit blood ves-
sel formation, leading to a reduced blood supply to the
tumour and consequential apoptosis of cancer cells.
Similarly to Glivec, the specificity of this drug moder-
ates its side effects. Furthermore, the compound has
been implicated in modulating the Wnt cascade via
stimulation of β-catenin degradation (85).
Other drugs that target β-catenin, promoting its
degradation, are Indomethacin, Sulindac and Aspirin;
these non-steroidal anti-inflammatory drugs
(NSAIDs) also prevent the transcription of target
genes, like Cyclin D1, halting tumour growth (see re-
view by (86)).
Therapies designed against Wnt pathway genetic
targets are not the only option for “molecular medi-
cine”. Alternative approaches, based on biological ex-
perimental methods, include the use of oncolytic
viruses to selectively lyse malignant cells, and of gene
therapy, using non-replicating viruses to introduce a
non-viral toxic gene, causing the death of target cells.
However, there is a major concern over the use of
these biologically-based mechanisms, due to the pos-
sible bio-hazard that the release of viruses represents,
and regarding the cost and duration of their produc-
tion, which is extremely high compared to other ther-
apeutical methods.
The application of low molecular weight organic
molecules to prevent the activation of TCF/β-catenin
target genes may offer a new therapeutic strategy, yet
it still requires refinement regarding toxicity and effi-
cacy of the compounds.
Numerous considerations need to be pondered
before the clinical application of the above anti-cancer
Table 3. Wnt pathway genes are linked to diverse human
pathologies. The spatial and functional eclecticism of the Wnt
signalling cascade is mirrored by the wide range of diverse dis-
eases caused by the pathway’s misregulation. Therefore, the
Wnt pathway finds itself not only implicated in carcinogenesis,
but also in numerous other diseases, which vary in their diffu-
sion, intensity and pathology. Table from Table 1 of a compre-





Wnt4 Intersex phenotype 
Kidney damage and Polycystic kidney
disease
SFRP3 Osteoarthritis
Fz4 Familial Exudative Vitreopathy (FEVR)
LPR5 FEVR 
Low or high bone mass 
Axin2 Tooth agenesis  
β-catenin Aggressive fibromatosis 
Pulmonary fibrosis
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therapeutics will be confirmed and achieved. Howev-
er, being able to target components of the Wnt path-
way aberrantly modulated during carcinogenesis has
profound implications on medical oncology and scien-
tific research in general, albeit no “anti-Wnt pathway”
cancer drugs are currently in use.
Nevertheless, the progress and improvement of
therapies based on the Wnt pathway strictly depend
on the advancements made in the understanding of
the Wnt signalling cascade and on the prompt trans-
lation of the scientific data into clinical implements.
Several pivotal questions still remain to be ad-
dressed regarding crucial steps and mechanisms of the
Wnt pathway. Firstly, there are still uncertainties
about steps of the molecular Wnt cascade. The mech-
anisms by which the frizzled receptor transfers the
Wnt signal into the cell via activation of Dishevelled,
and the subsequent deactivation of the β-catenin de-
struction complex by Dsh remain unclear. The phos-
phorylation events occurring throughout the pathway
are vital to the functions of the cascade, but the
modalities of control over these steps remain elusive.
In this regard, it will also be of great importance to de-
termine how β-catenin is transported into the nucle-
us, since the process could be an ideal target to halt the
Wnt target genes transcriptional activation.
Another major challenge will be to shed light on
the specificity of the Wnt pathway. Various Wnt lig-
ands can interact with different Frizzled receptors, un-
timately leading to the transcriptional activation of
several target genes leading to diverse outcomes in dif-
ferent cell types. It will therefore be interesting to as-
certain whether the different ligand-receptor pairs are
responsible for the pathway specificity or else the out-
come is determined solely by the cellular contexts.
Furthermore, taking into account that some target
genes can be promoted in multiple cell types and tis-
sues, it will be of key importance to establish if these
genes are “universal” Wnt pathway targets. The an-
swer to these questions will provide a better under-
standing of how the Wnt cascade is able to control the
complex balance between differentiation, proliferation
and migration.
In the near future, new models of gene activation
may be found for Wnt target genes that do not con-
tain a TCF/LEF binding site in the gene promoter re-
gion. In this instance, nuclear β-catenin has been
shown to mediate gene expression through other mol-
ecules, such as Sox17 in the specification of endoderm
(87); it is likely that a similar mechanism applies to
other cellular situations.
The identification of unknown players related to
the Wnt cascade will give new important insights, in
a near future.
One of the main aspects regards the Wnt con-
nection to tumourigenesis. Predictive screening
strategies can be designed by the identification of
function-altering polymorphisms in different tumour
types and by measurement and detection of nuclear
β-catenin levels. In addition, the analysis of the en-
dogenous differences between the responses that can-
cer cells have to selected anti-Wnt compounds may
provide new clues about the cellular activity of the
Wnt cascade.
The many unanswered questions suggest that,
despite incredible progress has been made in the pre-
sent-day understanding of this key pathway, the view
to which we have currently arrived is simply the be-
ginning of the story. A path has now been found, but
the road is still long, and a network of ways needs to
be explored to learn more about the functional and
mis-functional roles the Wnt pathway in humans. The
scientific knowledge gathered along these roads may
improve therapeutic modalities and optimise preven-
tion, endeavouring to fight many diseases, above all,
cancer.
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